Safety and Immunogenicity of Intradermal Fractional Dose Administration of the mRNA-1273 Vaccine: A Proof-of-Concept Study.

Publication

Safety and Immunogenicity of Intradermal Fractional Dose Administration of the mRNA-1273 Vaccine: A Proof-of-Concept Study.

Roozen, Geert V T; Prins, Margaretha L M; van Binnendijk, Rob; den Hartog, Gerco; Kuiper, Vincent P; Prins, Corine; Janse, Jacqueline J; Kruithof, Annelieke C; Feltkamp, Mariet C W; Kuijer, Marjan; Rosendaal, Frits R; Roestenberg, Meta; Visser, Leo G; Roukens, Anna H E

Type

Article

Language

en

Date

2022-10-25

Show all metadata

Title

Safety and Immunogenicity of Intradermal Fractional Dose Administration of the mRNA-1273 Vaccine: A Proof-of-Concept Study.

Published in

Annals of internal medicine 2022; 175(12):1771-1774

DOI

10.7326/M22-2089

PMID

URI

http://hdl.handle.net/10029/626198

Collections

Scientific articles and other publications